These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7868302)

  • 21. Vagal efferent stimulation protects against Mesobuthus tamulus venom-induced acute respiratory distress syndrome in rats.
    Akella A; Deshpande SB
    Toxicon; 2015 Dec; 108():189-201. PubMed ID: 26525658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of systemic complement activation on renal circulation of rats.
    Schlottmann K; Gulbins E; Rauterberg EW; Steinhausen M
    Eur J Clin Invest; 1994 May; 24(5):320-30. PubMed ID: 8088308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of complement activation with cobra venom factor on pulmonary vascular permeability.
    Johnson A; Cooper JA; Malik AB
    J Appl Physiol (1985); 1986 Dec; 61(6):2202-9. PubMed ID: 3027023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement depletion in a porcine model of septic acute respiratory disease.
    Dehring DJ; Steinberg SM; Wismar BL; Lowery BD; Carey LC; Cloutier CT
    J Trauma; 1987 Jun; 27(6):615-25. PubMed ID: 3599107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biologic variability in mechanical ventilation rate and tidal volume does not improve oxygenation or lung mechanics in canine oleic acid lung injury.
    Nam AJ; Brower RG; Fessler HE; Simon BA
    Am J Respir Crit Care Med; 2000 Jun; 161(6):1797-804. PubMed ID: 10852747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models.
    Vogel CW; Finnegan PW; Fritzinger DC
    Mol Immunol; 2014 Oct; 61(2):191-203. PubMed ID: 25062833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
    Cheung AK; Parker CJ; Wilcox L
    Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic relationships between human and cobra complement factors C3 and cobra venom factor (CVF) from the Indian cobra (Naja naja).
    Eggertsen G; Lundwall A; Hellman U; Sjöquist J
    J Immunol; 1983 Oct; 131(4):1920-3. PubMed ID: 6194220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletion.
    Vogel CW; Fritzinger DC
    Curr Pharm Des; 2007; 13(28):2916-26. PubMed ID: 17979736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effects of propofol on acute lung injury induced by oleic acid in conscious rats.
    Chen HI; Hsieh NK; Kao SJ; Su CF
    Crit Care Med; 2008 Apr; 36(4):1214-21. PubMed ID: 18379248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS).
    Reising CA; Chendrasekhar A; Wall PL; Paradise NF; Timberlake GA; Moorman DW
    J Surg Res; 1999 Mar; 82(1):56-60. PubMed ID: 10068526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of cobra venom factor on alternative pathway hemolytic activity in mice.
    Joiner KA; Hawiger A; Gelfand JA
    Immunol Commun; 1980; 9(3):277-81. PubMed ID: 7399569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular isoforms of cobra venom factor-like proteins in the venom of Austrelaps superbus.
    Rehana S; Manjunatha Kini R
    Toxicon; 2007 Jul; 50(1):32-52. PubMed ID: 17412383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin receptor blockade in canine oleic acid-induced lung injury.
    Hubloue I; Biarent D; Abdel Kafi S; Bejjani G; Mélot C; Naeije R; Leeman M
    Intensive Care Med; 2003 Jun; 29(6):1003-1006. PubMed ID: 12734647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Naja naja atra venom ameliorates pulmonary fibrosis by inhibiting inflammatory response and oxidative stress.
    Cui K; Kou JQ; Gu JH; Han R; Wang G; Zhen X; Qin ZH
    BMC Complement Altern Med; 2014 Dec; 14():461. PubMed ID: 25465226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic effect of anisodamine on acute lung injury induced by oleic acid in dogs].
    Wen FQ
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Apr; 12(2):99-102, 127. PubMed ID: 2791133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.
    Till GO; Morganroth ML; Kunkel R; Ward PA
    Am J Pathol; 1987 Oct; 129(1):44-53. PubMed ID: 3661679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of complement in endotoxin/platelet-activating factor-induced lung injury.
    Rabinovici R; Yeh CG; Hillegass LM; Griswold DE; DiMartino MJ; Vernick J; Fong KL; Feuerstein G
    J Immunol; 1992 Sep; 149(5):1744-50. PubMed ID: 1324280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant cobra venom factor.
    Vogel CW; Fritzinger DC; Hew BE; Thorne M; Bammert H
    Mol Immunol; 2004 Jun; 41(2-3):191-9. PubMed ID: 15159065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.